Sutro Biopharma Stock (NASDAQ: STRO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 767.29K |
Day Range | - - - |
52 Wk Range | 2.01 - 6.13 |
Market Cap | $307.36M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 3.72% |
Days to Cover | 4.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sutro Biopharma (NASDAQ:STRO) through any online brokerage.
Other companies in Sutro Biopharma’s space includes: Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR) and Zentalis Pharma (NASDAQ:ZNTL).
Sutro Biopharma has a consensus price target of $14.11.
The stock price for Sutro Biopharma (NASDAQ: STRO) is $3.75 last updated September 20, 2024 at 7:35 PM EDT.
There are no upcoming dividends for Sutro Biopharma.
Sutro Biopharma’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Sutro Biopharma.
Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.